Last updated: April 19, 2026

Application No. 18/022,252

METHODS OF NEUROPROTECTION AND USES THEREOF

Final Rejection

Filed

Feb 20, 2023

Examiner

AULAKH, CHARANJIT

Art Unit

1621

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

OA Round

2 (Final)

Interview Optional

— -16.0% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 1741 resolved cases, 2023–2026

Examiner Intelligence

AULAKH, CHARANJIT View full profile →

Grants 81% — above average

Career Allow Rate

1407 granted / 1741 resolved

+20.8% vs TC avg

Minimal -16% lift

Without

With

+-16.0%

Interview Lift

resolved cases with interview

Typical timeline

2y 3m

Avg Prosecution

54 currently pending

Career history

1795

Total Applications

across all art units

Statute-Specific Performance

§101

1.9%

-38.1% vs TC avg

§103

15.2%

-24.8% vs TC avg

§102

21.0%

-19.0% vs TC avg

§112

42.6%

+2.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1741 resolved cases

Prosecution Timeline

Feb 20, 2023

Application Filed

Jul 15, 2025

Non-Final Rejection

Dec 16, 2025

Response Filed

Jan 11, 2026

Final Rejection

Apr 14, 2026

Notice of Allowance

Precedent Cases

Applications granted by this same examiner with similar technology

18/248,841

Patent 12594251

BENZALKONIUM CHLORIDE FORUSE IN TREATING CONJUNCTIVITIS AND/OR COVID-19

2y 5m to grant Granted Apr 07, 2026

18/027,246

Patent 12583829

SALT OF BENZOTHIAZOLE COMPOUND, AND CRYSTAL FORM AND USE THEREOF

2y 5m to grant Granted Mar 24, 2026

17/760,077

Patent 12581852

COMPOUND, LUMINESCENT MATERIAL, DELAYED FLUORESCENT MATERIAL, AND ORGANIC OPTICAL DEVICE

2y 5m to grant Granted Mar 17, 2026

18/636,240

Patent 12569479

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

2y 5m to grant Granted Mar 10, 2026

17/906,541

Patent 12564586

KAPPA OPIOD RECEPTOR ANTAGONISTS FOR TREATING PAIN-RELATED SLEEP DISORDERS

2y 5m to grant Granted Mar 03, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

3-4

Expected OA Rounds

81%

Grant Probability

65%

With Interview (-16.0%)

2y 3m

Median Time to Grant

Moderate

PTA Risk

Based on 1741 resolved cases by this examiner. Grant probability derived from career allow rate.